Impact of Initiating a GLP1 Agonist and/or SGLT2 Inhibitor Therapy on De-Escalation and Discontinuation of Insulin and Diabetes Control When Managed by an Interprofessional Collaborative Team

CONCLUSION: Most patients initially overbasalized on insulin experienced a reduction in overbasalization after initiating GLP1 RA and/or SGLT2i. There was a notable A1C reduction, de-escalation, and deprescribing of insulin in patients receiving interprofessional collaborative care.PMID:38353180 | DOI:10.1177/21501319241231398

Source: Primary Care - February 14, 2024 Category: Primary Care Authors: Megan Champion Gabriel Wills Avila Angelica E Garcia Faviola M Álvarez Delgado Connie A Valdez Source Type: research